Argos Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Argos Wealth Advisors's BMY Position: Q2 2026 in Review
Argos Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.8% in Q2 2026, buying an estimated $5.34K and bringing the position to 11,693 shares worth $674K. The position accounts for 0.18% of the portfolio, ranked #64.
Argos Wealth Advisors first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $704K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Argos Wealth Advisors held 11,693 shares of Bristol-Myers Squibb worth $674K as of Q2 2026.
- Argos Wealth Advisors bought 93 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.34K.
- Bristol-Myers Squibb made up 0.18% of Argos Wealth Advisors's portfolio in Q2 2026, its #64 holding.
- Argos Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Argos Wealth Advisors's Bristol-Myers Squibb position peaked at $704K in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Argos Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.